<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">SODIUM OXYBATE (GHB)</span><br/>(sod'i-um ox'y-bate)<br/><span class="topboxtradename">Xyrem<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">cns depressant</span><br/><b>Pregnancy Category: </b>B<br/><b>Controlled Substance: </b>Schedule III<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>500 mg/mL solution</p>
<h1><a name="action">Actions</a></h1>
<p>CNS depressant; the precise mechanism by which sodium oxybate produces anticataplexy in narcolepsy is unknown. Sodium oxybate
         is GHB, a known drug of abuse.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Produces anticataplectic effects in narcolepsy and decreases the number of cataplexy events in individuals with narcolepsy.</p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of cataplexy in patients with narcolepsy.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Alcohol or sedative hypnotics or other CNS depressants; patients being treated with sedative hypnotic agents; psychosis; patients
         with succinic semialdehyde dehydrogenase deficiency; compromised respiratory drive, severe depression, or suicide tendencies;
         lactation; children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Hepatic dysfunction; compromised respiratory function; sleep disorders; history of seizures; heart failure, hypertension,
         impaired renal function; previous history of depressive illness or suicide attempt; elderly; sleep-walking; pregnancy (category
         B).
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Cataplexy</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> Start with 2.25 g given at bedtime while in bed and repeated 2.54 h later. Dose may be increased by 1.5 g/d every 2
               wk to a max of 9 g/d in 2 divided doses.<br/><br/><span class="impairmenttitle">Hepatic Impairment</span><br/>Reduce dose by 50% in patients with hepatic impairment<br/><br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give at bedtime at least 23 h after the evening meal.</li>
<li>Dilute each dose with 2 oz (60 mL) of water in the dosing cups provided.</li>
<li>Instruct patient to remain in bed after taking sodium oxybate.</li>
<li>Discard any diluted dose that has not been used within 24 h.</li>
<li>Store at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span>
<span class="speceff-common">Pain, infection,</span> flu-like syndrome, asthenia, allergic reactions, chills. <span class="typehead">CNS:</span> Confusion, depression, sleepwalking, <span class="speceff-common">headache, dizziness, somnolence,</span> nervousness, abnormal dreams, insomnia, agitation, ataxia, convulsion, stupor, tremor. <span class="typehead">CV:</span> Hypertension. <span class="typehead">GI:</span>
<span class="speceff-common">Nausea,</span> diarrhea, vomiting, dyspepsia, abdominal pain, anorexia, constipation. <span class="typehead">Metabolic:</span> Increased alkaline phosphatase, edema, hypercholesteremia, hypocalcemia, weight gain. <span class="typehead">Respiratory:</span>
<span class="speceff-common">Pharyngitis,</span> rhinitis, sinusitis <span class="typehead">Skin:</span> Increased sweating, acne, alopecia, rash. <span class="typehead">Special Senses:</span> Amblyopia, tinnitus. <span class="typehead">Urogenital:</span> Urinary incontinence, dysmenorrhea, albuminuria, cystitis, hematuria, metrorrhagia, urinary frequency. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Alcohol,</b>
<span class="classification">sedative-hypnotics</span>, other <span class="classification">cns depressants</span> may increase CNS depressant effects. <span class="typehead">Food:</span>
<b>High fat meal</b> will significantly reduce absorption. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Incompletely absorbed, 25% reaches systemic circulation. <span class="typehead">Peak:</span> 0.051.25 h. <span class="typehead">Metabolism:</span> Oxidized in the Kreb's cycle to carbon dioxide and water. <span class="typehead">Elimination:</span> Primarily eliminated as carbon dioxide in respiration. <span class="typehead">Half-Life:</span> 0.51 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for and report immediately any of the following: seizure, respiratory depression, or decreased level of consciousness.</li>
<li>Monitor closely patients with hepatic insufficiency for adverse events.</li>
<li>Monitor for and report excessive weight gain and development of edema.</li>
<li>Lab tests: Perform baseline LFTs; monitor periodically serum electrolytes and lipid profile.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not take sodium oxybate at any time other than at night, immediately before bedtime.</li>
<li>Be consistent with timing of the evening meal and take this drug at least 23 h after eating.</li>
<li>Prepare both doses prior to bedtime. After ingesting each dose remain in bed.</li>
<li>Do not consume alcohol or use other sedative hypnotic drugs with sodium oxybate.</li>
<li>Do not drive or engage in potentially hazardous activities until reaction to drug is known.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>